Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
A look back at some of the major news stories we covered this year.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
Similarities between these two mammals may boost human cancer research.
Kymriah, a novel CAR-T therapy, helps the immune system recognize and fight cancer.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
CAR-T therapy CTL019 trains immune system to recognize and fight cancer cells.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.